Geneyx company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Seed VC | Alive

Total Raised


Last Raised

$10M | 7 mos ago

About Geneyx

Geneyx has developed a universal genomic data-source. The Geneyx platform offers genetic testing labs and hospital-based facilities, as well as a secure, cloud-based data management and storage system. Geneyx enables pharma, universities, and institute based research groups to spearhead the development of drugs, novel therapeutic and diagnostic tools for the benefit of human health and well-being, using Geneyx's genetic data.

Geneyx Headquarter Location

22 Maskit St.

Herzliya, 4673322,


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Geneyx

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Geneyx is included in 1 Expert Collection, including Omics.



1,265 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data

Latest Geneyx News

Geneyx raises $10 million seed round for genetic data analysis platform

Nov 11, 2021

Geneyx raises $10 million seed round for genetic data analysis platform The Israeli startup's funding round was led by Capri Ventures and Accenture Ventures, with Geneyx to also join Accenture’s Project Spotlight Accelerator Program CTech 13:0011.11.21 Geneyx Genomex, an Israel-based developer of genetic data analysis and interpretation platform, has announced that it has closed a $10 million seed round led by Capri Ventures and Accenture Ventures. Geneyx leverages AI to improve risk prediction, diagnostic yield, prognostic prediction, and treatment insights supporting clinical decision-making and biopharmaceutical research, helping to accelerate the development of targeted and personalized therapeutics. “The investment from Capri Ventures and Accenture Ventures, will enable our next phase of global growth and expansion in support of patients who desperately need diagnostic answers and treatments for their conditions,” said David Yizhar, CEO at Geneyx. “Our solutions have already been used in more than 100,000 cases across 18 countries and cited in more than 50 peer-reviewed publications. In the next two years, we aim to enable our users to achieve 90% diagnostic yield, utilizing whole-genome sequencing for varied medical conditions. And we are getting closer every day." Accenture building. Photo: Getty   Geneyx also joined Accenture Ventures’ Project Spotlight, an engagement and investment program that connects emerging technology software startups with the Global 2000 to fill strategic innovation gaps. Project Spotlight offers extensive access to Accenture’s domain expertise and its enterprise clients. The companies plan to leverage Accenture’s dataset of 55 million de-identified patient electronic medical records to further joint initiatives. Related articles:

Geneyx Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Geneyx Rank

  • When was Geneyx founded?

    Geneyx was founded in 2018.

  • Where is Geneyx's headquarters?

    Geneyx's headquarters is located at 22 Maskit St., Herzliya.

  • What is Geneyx's latest funding round?

    Geneyx's latest funding round is Seed VC.

  • How much did Geneyx raise?

    Geneyx raised a total of $10M.

  • Who are the investors of Geneyx?

    Investors of Geneyx include Accenture Ventures and Capri Ventures.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.